Patent Office Trials Blog
  • 5/9/2019

    There are two categories of prior art under the America Invents Act (AIA). 35 U.S.C. §102(a)(1) prior art disclosures, including patents, which are considered prior art as of their grant date; printed publications, which are considered prior art as of their publication date; and evidence that the claimed invention was in public use, on sale, or otherwise available to the public, which are eligible as prior art as of the date of public use or offer for sale. 35 U.S.C. §102(a)(2) prior art includes U.S. patents, U.S. pre-grant patent application publications and WIPO published applications that designate the United States. These patents and patent publications are eligible as prior art as of their effective filing date. Our presentation is directed to the different types of prior art disclosure set forth in §102(a)(1). We will refer to the Manual of Patent Examination Procedure (MPEP) and recent case law.

    The lecture will take place on May 9th, 2019 at 12:00 PM at Sughrue's Washington, D.C. Office (6th floor). For more information, click here.

  • 5/6/2019
    Sughrue is proud to announce the recognition of partners Jody H. Drake and Gary D. Krugman as expert trademark attorneys in the United States for 2019. Legal Media Group's Expert Guides- Best of the Best USA is a guide to the top legal practitioners in the United States across 16 areas of law. "Expert Guides has been researching the world's legal markets for 25 years, and has become one of the most trusted resources for international buyers of legal services." Congratulations to Ms. Drake and Mr. Krugman for this notable acknowledgement of consistently excellent work.
  • 4/4/2019
    Managing Intellectual Property hosted its annual IP Stars Americas Awards 2019 on April 4th, where it named Sughrue Mion as winner of the Impact Case of the Year Award. This award is a proud acknowledgement for Sughrue's work on Saint Regis Mohawk Tribe, Allergan Inc. v. Mylan Pharmaceuticals, Teva Pharmaceuticals USA, Akorn, Inc., a case which defendants invalidated the asserted patents covering Allergan's Restasis® opthalmic emulsion. After Allergan assigned its patents to the Tribe, the Tribe sought dismissal of the parallel IPR based on Tribal sovereign immunity. The Federal Circuit affirmed the patent judgment, and in a separate appeal, rejected the invocation of Tribal sovereign immunity in IPR proceedings. Partners Michael Dzwonczyk and Mark Boland, who spearheaded the case's success, represented the firm by accepting the award at the renowned event. Sughrue is excited and honored to have received such an exemplary award.
  • 3/28/2019

    The Internet of Things (IoT) is a network of devices including electronics and software that allow these so-called "things" to exchange data. Many titans of the tech industry are now selling IoT devices and are thus obtaining patents on such devices, preparing for potential patent wars. The rapid rise of IoT devices raises issues of indirect infringement of U.S. patents. This presentation will introduce these indirect infringement issues and provide key patent prosecution strategies to tackle the confounding issues.

    The lecture will take place on March 28th, 2019 at 12:00 PM at Sughrue's Washington, D.C. Office (6th floor). For more information, click here.

More News